WellPoint Health Networks Inc.
http://www.wellpoint.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From WellPoint Health Networks Inc.
Boehringer Files Pradaxa Antidote, Could Lead To Reversible Novel Anticoagulant
Finishing off a rolling BLA, company believes that the specific antidote for its novel anticoagulant Pradaxa will be eligible for accelerated approval based on Phase I data in volunteers.
Boehringer Files Pradaxa Antidote, Could Be First Reversible Novel Anticoagulant
Finishing off a rolling BLA, company believes that the specific antidote for its novel anticoagulant Pradaxa will be eligible for accelerated approval based on Phase I data in volunteers.
ACA Formulary Standards Incorporating P&T Review Supported By Stakeholders
Insurers and pharmaceutical companies urge CMS to allow health plans to use their pharmacy and therapeutics committees to design formularies for individual and small group plans.
The Donut Hole Dilemma: Retaining Lost Patients Under Medicare Part D
Finally, some statistics about the impact of the Medicare Part D donut hole. The good news: drug manufacturers need not worry about most patients entering the coverage gap. The bad: a relatively large number of the industry's best customers do reduce their medication use in the donut hole-and if a customer is lost to the donut hole, they may be lost for good.
Company Information
- Industry
- Services
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice